Price Alert

Voyager Therapeutics Inc. (VYGR)

NASDAQ: VYGR · Real-Time Price · USD

3.42

0.00 (0.00%)

At close: Aug 27, 2025, 3:59 PM

3.42

0.00%

After-hours: Aug 27, 2025, 07:38 PM EDT

Voyager Therapeutics Statistics

Share Statistics

Voyager Therapeutics has 55.47M shares outstanding. The number of shares has increased by 1.47% in one year.

Shares Outstanding	55.47M
Shares Change (YoY)	1.47%
Shares Change (QoQ)	0.23%
Owned by Institutions (%)	52.74%
Shares Floating	45.31M
Failed to Deliver (FTD) Shares	8
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 3.21M, so 5.8% of the outstanding shares have been sold short.

Short Interest	3.21M
Short % of Shares Out	5.8%
Short % of Float	6.91%
Short Ratio (days to cover)	4.9

Valuation Ratios

The PE ratio is -5.03 and the forward PE ratio is -2.24. Voyager Therapeutics's PEG ratio is 0.04.

PE Ratio	-5.03
Forward PE	-2.24
PS Ratio	4.09
Forward PS	3
PB Ratio	1.09
P/FCF Ratio	-17.36
PEG Ratio	0.04

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Voyager Therapeutics.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.56, with a Debt / Equity ratio of 0.15.

Current Ratio	5.56
Quick Ratio	5.56
Debt / Equity	0.15
Debt / EBITDA	-0.56
Debt / FCF	-2.32
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$465.12K
Profits Per Employee	$-377.92K
Employee Count	172
Asset Turnover	0.2
Inventory Turnover	n/a

Taxes

Income Tax	665K
Effective Tax Rate	-1.03%

Stock Price Statistics

The stock price has increased by -48.42% in the last 52 weeks. The beta is 0.9, so Voyager Therapeutics's price volatility has been higher than the market average.

Beta	0.9
52-Week Price Change	-48.42%
50-Day Moving Average	3.27
200-Day Moving Average	4.23
Relative Strength Index (RSI)	51.23
Average Volume (20 Days)	787,142

Income Statement

In the last 12 months, Voyager Therapeutics had revenue of 80M and earned -65M in profits. Earnings per share was -1.13.

Revenue	80M
Gross Profit	80M
Operating Income	-83.29M
Net Income	-65M
EBITDA	-78.56M
EBIT	-83.29M
Earnings Per Share (EPS)	-1.13

Full Income Statement

Balance Sheet

The company has 71.37M in cash and 43.73M in debt, giving a net cash position of 27.64M.

Cash & Cash Equivalents	71.37M
Total Debt	43.73M
Net Cash	27.64M
Retained Earnings	-326.18M
Total Assets	322.1M
Working Capital	185.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.31M and capital expenditures -3.52M, giving a free cash flow of -18.83M.

Operating Cash Flow	-15.31M
Capital Expenditures	-3.52M
Free Cash Flow	-18.83M
FCF Per Share	-0.33

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -104.11% and -81.25%.

Gross Margin	100%
Operating Margin	-104.11%
Pretax Margin	-80.42%
Profit Margin	-81.25%
EBITDA Margin	-98.19%
EBIT Margin	-104.11%
FCF Margin	-23.54%

Dividends & Yields

VYGR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for VYGR is $12, which is 250.9% higher than the current price. The consensus rating is "Buy".

Price Target	$12
Price Target Difference	250.9%
Analyst Consensus	Buy
Analyst Count	7

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-0.8
Piotroski F-Score	1